VO2 max intervalssupports
“Now my single highest-leverage Rx.”
2025-01-22 · Newsletter 2025-01View on protocol →
Stanford Longevity Lab
Clinician-researcher focused on cardiometabolic risk and translational longevity.
Hover any dot to read the position. Click to jump to the card below.
Across the protocols both they and we cover.
Reasons forward from physiology before reaching for endpoint data.
Will discount even large cohorts if a tightly-controlled trial points the other way.
Routinely flags when his prior view shifted and explains why.
Comfortable saying 'probably this dose' rather than overstating precision.
“Now my single highest-leverage Rx.”
“The single most evidence-backed intervention.”
“Stronger position now after CLEAR Outcomes.”
“Worth the discomfort.”